Supplemental Table 2. Demographic Features of AAV Patients from Latin America, Europe, Asia and Australia.
Pimentel -Quiroz et al [13]
(n=212)
Fernández -Ávila et al [10]
(n=106) Varga s et al [11]
(n=65 )
Cisterna s et al
[15]
(n=123)
Belem et al [22]
(n=295)
Pierini et al [8]
(n=47)
Pérez et al [12]
(n=41) d Paolini et al [16]
(n=38) d Cervera -Castillo et al [14]
(n=28) e Hinojosa
-Azaola et al [19]
(n=40) Flores- Suárez et al
[9]
(n=90) Berti et
al [68]
(n=58) Sada et al [29]
(n=125 ) f
Liu et al [30]
(n=209 ) g
Pamu k et al [72]
(n=45 )
Mahr et al [69]
(n=45)
h
Solans- Laqué et al [73]
(n=351 ) g
Ponte et al [74]
(n=92)
Mohamma d et al [70]
(n=128) i
Ormero d et al [28]
(n=54)
Gibson et al [75]
(n=101)
Continen
t America Asia Europe Australia
Country Peru Colombia Chile Chile
Brazil (southeas
t region)
Argentin a
Argentin a
Argentin
a Mexico Mexico Mexic
o USA (Olmste
d County)
Japan China Turke
y
France (Seine –St.
Denis County
)
Spain Portuga
l Sweden
Capital territory
– New South Wales
New Zealand (Canterbury
)
Female, n (%)
139
(65.6) 61 (57.5) 38
(58.5) 77 (62.6)
174
(59.0) 35 (74.5) 23 (56.1) 23 (60.5) 15 (53.6)
23 (57.5)
55 (61.1%
) 28 (48.3)
73 (58.4)
107 (51.2)
20 (44.4)
31 (45.6)
173 (49.3)
62
(67.4) 65 (50.8) 28
(51.9) 56 (55.5) Age at
diagnosis
a
59.2 (12.5)
56.0 (14.7)
53 .0 (45.0- 63.0) c
NR NR NR 53.5
(16.5) 54.1 (15.9)
50.1 (12.7)
53.0 (37.0- 58.0) c
42.0 (12.0)
61.1
(16.5) NR 59.5
(15.4) 52.6 (14.9)
50.3 (17.6)
55.6
(17.3) NR 67.6 (20.0-
62.0) c NR NR
MPA
n (%) 165
(77.8) b 48 (45.3) 30 (46.2)
65
(52.8) 42 (14.2) 28 (59.6) 17 (41.5) 15 (39.5) 0 5 (12.5) 10
(11.1) 28 (48.3)
78 (62.4)
172 (82.3)
15 (33.3)
16 (23.5)
167 (47.6)
22
(23.9) 65 (50.8) 16
(29.6) 28 (27.7) Female,
n (%) 117
(71.0) 28 (58.3) NR 44
(67.7) 27 (64.3) 21 (75%) 12 (70.6) 12 (80.0) 0 NR 9
(90.0) 15 (53.6)
43 (55.1)
88 (51.2)
10 (66.7)
11 (68.8)
83 (49.7)
17
(77.3) 35 (53.8) 7 (43.8) 11 (39.3) Age at
diagnosis 61.1 (11.5)
60.0
(14.7) NR 58.7
(15.5) 47.6 (15.5)
73.6 (13.2)
58.1 (18.8)
57.9
(16.1) 0 NR 47.0
(11.0) 67.7 (16.2)
71.1 (10.0)
61.7 (13.9)
61.5 (14.2)
60.2 (14.3)
63.8 (16.2)
60.7 (12.3)
70.0 (29.0- 92.0) c
63.0 (6.0- 75.0) c
70.5 (41.0- 94.0) c GPA
n (%) 42 (19.8) 56 (52.8) 35 (53.8)
58 (47.2)
200
(67.8) 19 (40.4) 20 (48.8) 23 (60.5) 20 (71.4)
35 (87.5)
74 (82.2)
23 (39.7)
33 (26.4)
37 (17.7)
30 (66.7)
21 (30.9)
184 (52.4)
41
(44.6) 63 (49.2) 38
(70.4) 73 (72.3) Female,
n (%) 21 (50.0) 32 (57.1) NR 33
(56.9) 119
(59.2) 14 (73.7) 9 (45.0) 11 (47.8) NR NR 44
(59.5) 12 (52.2)
21 (63.6)
19 (51.4)
10 (33.3)
9 (42.9)
90 (48.9)
25
(61.0) 30 (47.6) 21
(55.3) 45 (61.6) Age at
diagnosis 53.4 (14.1)
59.0
(14.8) NR 50.8
(14.0) 41.9 (14.9)
69.8 (11.3)
52.1 (16.0)
55.1
(16.1) NR NR 42.0
(12.0) 56.1 (15.1)
63.6 (12.6)
51.5 (17.5)
49.8 (13.3)
50.6 (17.9)
49.9 (16.3)
50.0 (14.1)
67.6 (20.0- 84.0) c
55.0 (14.0- 78.0) c
66.0 (27.0- 91.0) c AAV: ANCA-associated vasculitis; MPA: Microscopic polyangiitis; GPA: Granulomatosis with polyangiitis; NR: Not reported.
a Mean and standard deviation, except where otherwise is indicated.
b Renal-limited vasculitis patients were included.
c Median and interquartile range.
d Renal-limited vasculitis were excluded.
e Eosinophilic granulomatosis with polyangiitis patients were included.
f Unclassifiable patients (n=31) were excluded.
g Eosinophilic granulomatosis with polyangiitis patients were excluded.
h Polyarteritis nodosa patients (n=23) were excluded.
i Eosinophilic granulomatosis with polyangiitis and polyarteritis nodosa patients were excluded.
